MTOR and uveal melanoma: The mTOR inhibitors alone slightly increased apoptosis in some uveal melanoma cell lines; however, the combination of the mTOR inhibitors with romidepsin resulted in increased apoptosis in all uveal melanoma cell lines studied, except for the 92.1 cell line, which was highly sensitive to short-term romidepsin treatment alone.